Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States
- Status
- COMPLETED
- Phase
- N/A
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of OB-002 in Patients With Refractory Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
The Impact of Radiotherapy on Oligometastatic Cancer
- Status
- RECRUITING
- Phase
- N/A
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- N/A
Circulating Tumor Cells and Neutrophils Count for Colorectal Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
- Status
- RECRUITING
- Phase
- N/A
SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2